№ lp_2_3_12346
Corporate regulatory filing submitted to the Securities and Exchange Commission reporting amendments to the company’s by-laws approved by the board of directors and providing related corporate and securities registration information.
Year: 2019
Date of Report: October 22, 2019
Date of Earliest Event Reported: October 17, 2019
Company: AbbVie Inc.
State of Incorporation: Delaware
IRS Employer Identification No.: 32-0375147
Commission File Number: 001-35565
Principal Executive Offices: 1 North Waukegan Road, North Chicago, Illinois 60064-6400
Telephone: (847) 932-7900
Stock Exchange Listings: New York Stock Exchange; Chicago Stock Exchange
Trading Symbols: ABBV; ABBV24; ABBV27; ABBV28; ABBV31
Securities Registered: Common Stock, $0.01 Par Value; 1.375% Senior Notes due 2024; 0.750% Senior Notes due 2027; 2.125% Senior Notes due 2028; 1.250% Senior Notes due 2031
Legal Basis: Securities Exchange Act of 1934
Reporting Form: Form 8-K
Items Reported: Item 5.03; Item 9.01
Governing Law Referenced: General Corporation Law of the State of Delaware
Board Action Date: October 17, 2019
Signatory: Laura J. Schumacher, Vice Chairman, External Affairs, Chief Legal Officer, and Corporate Secretary
Exhibit: Amended and Restated By-laws of AbbVie Inc. adopted on October 17, 2019
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.